What
is the most important information I should know about rilpivirine?
•
Rilpivirine
is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) being
developed by Tibotec, a biotechnology company in Belgium. It has not yet been
evaluated by the U.S. Food and Drug Administration (FDA) for use by people living
with HIV.
What
is rilpivirine?
•
Rilpivirine
is in a category of HIV medicines called non-nucleoside reverse transcriptase
inhibitors (NNRTIs). Rilpivirine prevents HIV from entering the nucleus of healthy
T-cells. This prevents the cells from producing new virus and decreases the amount
of virus in the body.
